Specify a stock or a cryptocurrency in the search bar to get a summary
Ekso Bionics Holdings Inc
EKSOEkso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therap, an adjustable and lower-limb powered exoskeleton; and Ekso Indego Personal, a powered lower limb orthosis. It has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in San Rafael, California. Address: 1414 Harbour Way South, Richmond, CA, United States, 94804
Analytics
WallStreet Target Price
9 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures EKSO
Dividend Analytics EKSO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History EKSO
Stock Valuation EKSO
Financials EKSO
Results | 2019 | Dynamics |